广发医药创新混合发起式C(017963)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
1,110,293.95 |
1,053,337.72 |
56,855.66 |
106,698.32 |
| 存出保证金 |
68,109.30 |
9,998.17 |
7,211.04 |
11,867.13 |
| 交易性金融资产 |
184,134,496.96 |
37,490,715.62 |
25,486,944.59 |
28,965,921.29 |
| 其中：股票投资 |
181,107,054.05 |
36,177,557.48 |
25,079,300.10 |
28,965,921.29 |
| 债券投资 |
3,027,442.91 |
1,313,158.14 |
407,644.49 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
37,250.29 |
- |
- |
| 应收申购款 |
4,720,496.66 |
300,564.51 |
2,109.25 |
47,074.48 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
211,065,318.98 |
41,473,813.00 |
27,054,783.37 |
32,877,466.51 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
18.85 |
1,911,076.23 |
1.23 |
675.02 |
| 应付赎回款 |
16,396,371.25 |
565,565.38 |
327,942.03 |
122,762.95 |
| 应付管理人报酬 |
248,975.58 |
35,577.13 |
28,901.49 |
33,698.21 |
| 应付托管费 |
41,495.95 |
5,929.50 |
4,816.90 |
5,616.38 |
| 应付销售服务费 |
99,390.11 |
4,658.80 |
1,902.06 |
2,967.31 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
366,770.74 |
43,318.76 |
75,123.10 |
86,697.43 |
| 负债合计 |
17,153,022.48 |
2,566,125.80 |
438,686.81 |
252,417.30 |
| 所有者权益 |
| 实收基金 |
163,124,838.42 |
31,026,875.00 |
28,855,699.22 |
33,238,937.16 |
| 未分配利润 |
30,787,458.08 |
7,880,812.20 |
-2,239,602.66 |
-613,887.95 |
| 所有者权益合计 |
193,912,296.50 |
38,907,687.20 |
26,616,096.56 |
32,625,049.21 |
| 负债及所有者权益总计 |
211,065,318.98 |
41,473,813.00 |
27,054,783.37 |
32,877,466.51 |
微信公众号
证券之星APP
基本资料
